Research indicates that individuals with psychiatric diagnoses or trait characteristics, including depression, borderline personality disorder, or high trait aggression, may be susceptible to adverse social or emotional consequences following oxytocin administration [92]. Here, OXT is linked to depressive symptom measurement.